CRB Inverbío

Overview

CRB Inverbío is a Spanish venture capital firm specializing in early-stage investments in life sciences companies addressing unmet medical needs. The firm focuses on sectors such as biotechnology, medtech, digital health, and medical devices, providing financing, management support, and strategic advice to innovative projects led by experienced scientists and entrepreneurs. CRB Inverbío manages multiple funds, including CRB Bio II, a €60 million venture capital fund investing in emerging life sciences companies. The firm has a track record of over 35 investments in digital health over the past four years, with early exits like DentalXr achieving a 2.4x return in 1.5 years. CRB Inverbío's investment philosophy emphasizes a hands-on approach, leveraging a broad network of expertise, including scientific advisory boards, venture partners, portfolio CEOs, key opinion leaders, and both local and global partners. The firm seeks to support companies developing medical products, therapeutic solutions, and diagnostic technologies, as well as applications of biotechnology in agriculture and animal health, aiming for exits within three to five years.

Investment Focus

• Innovative projects addressing unmet medical needs
• Led by experienced scientists and entrepreneurs
• Focus on life sciences sectors such as biotechnology, medtech, digital health, and medical devices
• Early-stage companies with high growth potential
• Companies developing medical products, therapeutic solutions, and diagnostic technologies
• Applications of biotechnology in agriculture and animal health
• Projects with a clear path to commercialization and exit within three to five years

Portfolio Companies